Lonza Group reported CHF10.6B in Equity Capital and Reserves for its second fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Akzo Nobel AKZA:NA EUR 5.12B 81M
Alcon AG ALC:SW USD 19.65B 106M
AstraZeneca AZN:LN USD 35.13B 798M
BASF BAS:GR EUR 47.61B 2.66B
Bayer BAYN:GR EUR 41.27B 3.25B
Covestro 1COV:GR EUR 8.62B 182M
Fresenius FRE:GR EUR 21.38B 718M
Fresenius Medical Care FME:GR EUR 15.05B 399.58M
Genmab GEN:DC DKK 26.66B 2.18B
Givaudan GIVN:VX CHF 4.02B 87M
GlaxoSmithKline GSK:LN GBP 10.6B 1.45B
GN Store Nord GN:DC DKK 7.2B 564M
Hikma Pharmaceutical HIK:LN USD 2.18B 277M
Johnson Matthey JMAT:LN GBP 2.54B 102M
Merck MRK:GR EUR 28.26B 2.31B
Novartis NOVN:VX USD 60.82B 2.1B
Roche Holding ROG:VX 25.19B 700M
Smith & Nephew PLC SN/:LN 5.4B 173M
Solvay SOLB:BB EUR 11.26B 807M
William Demant Holding WDH:DC DKK 8.18B 202M